| Name | Crexavibart |
|---|
| Description | Crexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain[1]. |
|---|---|
| Related Catalog | |
| Target |
SARS-CoV2[1] |
| No Any Chemical & Physical Properties |